Exact Mass: 488.1171

Exact Mass Matches: 488.1171

Found 34 metabolites which its exact mass value is equals to given mass value 488.1171, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Citicoline

2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethanaminium

C14H26N4O11P2 (488.1073)


CDP-choline is a member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. It has a role as a human metabolite, a psychotropic drug, a neuroprotective agent, a Saccharomyces cerevisiae metabolite and a mouse metabolite. It is a member of phosphocholines and a member of nucleotide-(amino alcohol)s. It is functionally related to a CDP. It is a conjugate base of a CDP-choline(1+). Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides. It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others. Citicoline is a nutritional supplement and source of choline and cytidine with potential neuroprotective and nootropic activity. Citicoline, also known as cytidine-5-diphosphocholine or CDP-choline, is hydrolyzed into cytidine and choline in the intestine. Following absorption, both cytidine and choline are dispersed, utilized in various biosynthesis pathways, and cross the blood-brain barrier for resynthesis into citicoline in the brain, which is the rate-limiting product in the synthesis of phosphatidylcholine. This agent also increases acetylcholine (Ach), norepinephrine (NE) and dopamine levels in the central nervous system (CNS). In addition, citicoline is involved in the preservation of sphingomyelin and cardiolipin and the restoration of Na+/K+-ATPase activity. Citicoline also increases glutathione synthesis and glutathione reductase activity, and exerts antiapoptotic effects. Donor of choline in biosynthesis of choline-containing phosphoglycerides. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics Acquisition and generation of the data is financially supported in part by CREST/JST. D002491 - Central Nervous System Agents > D018697 - Nootropic Agents Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

Tonapofylline

6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-1,2-dihydroquinolin-2-one

C27H22Cl2N4O (488.1171)


   

Cytidine-5'-diphosphocholine

{2-[({[5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphono)oxy]ethyl}trimethylazanium

C14H26N4O11P2 (488.1073)


D002491 - Central Nervous System Agents > D018697 - Nootropic Agents

   

Protocercosporin

Protocercosporin

C27H20O9 (488.1107)


   

Xanthoviridicatin E

Xanthoviridicatin E

C27H20O9 (488.1107)


   
   

squarrosidine

squarrosidine

C27H20O9 (488.1107)


   

cytidine 5-diphosphocholine

cytidine 5-diphosphocholine

C14H26N4O11P2 (488.1073)


   

Suncholin

Cytidine-5-diphosphocholine sodium salt dihydrate, from yeast, solid

C14H26N4O11P2 (488.1073)


Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

Citicoline

2-(((((((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)-N,N,N-trimethylethanaminium

C14H26N4O11P2 (488.1073)


CDP-choline is a member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes. It has a role as a human metabolite, a psychotropic drug, a neuroprotective agent, a Saccharomyces cerevisiae metabolite and a mouse metabolite. It is a member of phosphocholines and a member of nucleotide-(amino alcohol)s. It is functionally related to a CDP. It is a conjugate base of a CDP-choline(1+). Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides. It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others. Citicoline is a nutritional supplement and source of choline and cytidine with potential neuroprotective and nootropic activity. Citicoline, also known as cytidine-5-diphosphocholine or CDP-choline, is hydrolyzed into cytidine and choline in the intestine. Following absorption, both cytidine and choline are dispersed, utilized in various biosynthesis pathways, and cross the blood-brain barrier for resynthesis into citicoline in the brain, which is the rate-limiting product in the synthesis of phosphatidylcholine. This agent also increases acetylcholine (Ach), norepinephrine (NE) and dopamine levels in the central nervous system (CNS). In addition, citicoline is involved in the preservation of sphingomyelin and cardiolipin and the restoration of Na+/K+-ATPase activity. Citicoline also increases glutathione synthesis and glutathione reductase activity, and exerts antiapoptotic effects. Donor of choline in biosynthesis of choline-containing phosphoglycerides. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

Nicholin

cytidine 5-diphosphocholine

C14H26N4O11P2 (488.1073)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

Recofnan

Cytidine-5-diphosphocholine sodium salt dihydrate, from yeast, solid

C14H26N4O11P2 (488.1073)


Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects. Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.

   

CYTIDINE 5'-DIPHOSPHOCHOLINE

CYTIDINE 5'-DIPHOSPHOCHOLINE

C14H26N4O11P2 (488.1073)


   

CDP-Choline; LC-tDDA; CE10

CDP-Choline; LC-tDDA; CE10

C14H26N4O11P2 (488.1073)


   

CDP-Choline; LC-tDDA; CE20

CDP-Choline; LC-tDDA; CE20

C14H26N4O11P2 (488.1073)


   

CDP-Choline; LC-tDDA; CE30

CDP-Choline; LC-tDDA; CE30

C14H26N4O11P2 (488.1073)


   

CDP-Choline; LC-tDDA; CE40

CDP-Choline; LC-tDDA; CE40

C14H26N4O11P2 (488.1073)


   

Tipifarnib

Tipifarnib

C27H22Cl2N4O (488.1171)


C471 - Enzyme Inhibitor > C2020 - Farnesyl Transferase Inhibitor D000970 - Antineoplastic Agents

   

N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-(diallylamino)-4-methoxyphenyl]acetamide

N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-(diallylamino)-4-methoxyphenyl]acetamide

C21H21ClN6O6 (488.1211)


   

2(1H)-Quinolinone, 6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-

2(1H)-Quinolinone, 6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-

C27H22Cl2N4O (488.1171)


D000970 - Antineoplastic Agents

   

Tipifarnib S enantiomer

Tipifarnib S enantiomer

C27H22Cl2N4O (488.1171)


   

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[hydroxy-[(4-nitrophenyl)methoxy]methyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[hydroxy-[(4-nitrophenyl)methoxy]methyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C18H24N4O10S (488.1213)


   

2-[(3R,8Z,11S)-3-(4-chlorophenyl)-5,12-dioxo-1-oxa-4-azacyclododec-8-en-11-yl]-N-[(4-chlorophenyl)methyl]acetamide

2-[(3R,8Z,11S)-3-(4-chlorophenyl)-5,12-dioxo-1-oxa-4-azacyclododec-8-en-11-yl]-N-[(4-chlorophenyl)methyl]acetamide

C25H26Cl2N2O4 (488.127)


   

(3E)-2-(4-Chloroanilino)-5-(4-chlorophenyl)-3-isopropylimino-phenazin-1-OL

(3E)-2-(4-Chloroanilino)-5-(4-chlorophenyl)-3-isopropylimino-phenazin-1-OL

C27H22Cl2N4O (488.1171)


   

6-[(S)-amino-(4-chlorophenyl)-(3-methyl-4-imidazolyl)methyl]-4-(3-chlorophenyl)-1-methyl-2-quinolinone

6-[(S)-amino-(4-chlorophenyl)-(3-methyl-4-imidazolyl)methyl]-4-(3-chlorophenyl)-1-methyl-2-quinolinone

C27H22Cl2N4O (488.1171)


   

CDP-choline

CDP-choline

C14H26N4O11P2 (488.1073)


A member of the class of phosphocholines that is the chloine ester of CDP. It is an intermediate obtained in the biosynthetic pathway of structural phospholipids in cell membranes.

   
   

3-{9,10-dihydroxy-7-methoxy-3-methyl-1-oxobenzo[g]isochromen-8-yl}-5-hydroxy-2-methoxy-7-methylnaphthalene-1,4-dione

3-{9,10-dihydroxy-7-methoxy-3-methyl-1-oxobenzo[g]isochromen-8-yl}-5-hydroxy-2-methoxy-7-methylnaphthalene-1,4-dione

C27H20O9 (488.1107)


   

7,10,15,16-tetrahydroxy-8-methoxy-3-methyl-3,4,6,7-tetrahydro-2-oxahexaphene-1,9,14-trione

7,10,15,16-tetrahydroxy-8-methoxy-3-methyl-3,4,6,7-tetrahydro-2-oxahexaphene-1,9,14-trione

C27H20O9 (488.1107)


   

{2-[({[(2s,3s,4r,5s)-3,4-dihydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)oxolan-2-yl]methyl phosphonato}oxy(hydroxy)phosphoryl)oxy]ethyl}trimethylazanium

{2-[({[(2s,3s,4r,5s)-3,4-dihydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)oxolan-2-yl]methyl phosphonato}oxy(hydroxy)phosphoryl)oxy]ethyl}trimethylazanium

C14H26N4O11P2 (488.1073)


   

3-({6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}methyl)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethenyl]pyran-2-one

3-({6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}methyl)-4-hydroxy-6-[2-(4-hydroxyphenyl)ethenyl]pyran-2-one

C27H20O9 (488.1107)


   

(7r)-7,10,15,16-tetrahydroxy-8-methoxy-3-methyl-3,4,6,7-tetrahydro-2-oxahexaphene-1,9,14-trione

(7r)-7,10,15,16-tetrahydroxy-8-methoxy-3-methyl-3,4,6,7-tetrahydro-2-oxahexaphene-1,9,14-trione

C27H20O9 (488.1107)


   

3-({6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}methyl)-4-hydroxy-6-[(1e)-2-(4-hydroxyphenyl)ethenyl]pyran-2-one

3-({6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}methyl)-4-hydroxy-6-[(1e)-2-(4-hydroxyphenyl)ethenyl]pyran-2-one

C27H20O9 (488.1107)


   

3,10,15,16-tetrahydroxy-8-methoxy-3-methyl-6,7-dihydro-4h-2-oxahexaphene-1,9,14-trione

3,10,15,16-tetrahydroxy-8-methoxy-3-methyl-6,7-dihydro-4h-2-oxahexaphene-1,9,14-trione

C27H20O9 (488.1107)